神经诊断市场，依产品类型（脑电图系统、磁振造影系统、超音波影像系统、电脑断层扫描仪、试剂和耗材等）、按治疗领域、按最终用户、按地理位置

神经诊断市场预计 2024 年价值为 86.6 亿美元，预计到 2031 年将达到 149.1 亿美元，2024 年至 2031 年年复合成长率(CAGR) 为 8.1%。

数字。神经诊断市场占有率 (%)，依地区 2024 年

神经诊断是指透过各种影像和监测技术诊断神经系统疾病。它涉及评估中枢和周围神经系统是否存在任何异常。由于阿兹海默症、帕金森氏症、癫痫、中风和影响神经系统的各种癌症等神经系统疾病的发生率不断上升，神经诊断市场在过去几年中出现了显着增长。神经影像技术的进步和新型生物标记的开发使得这些疾病的早期、准确诊断成为可能。此外，越来越多的老年人口更容易患神经系统疾病、医疗保健支出增加以及报销的可及性是预计未来几年推动神经诊断需求的一些关键因素。

市场动态：

全球神经诊断市场主要是由全球神经系统疾病盛行率上升所推动的。根据世界卫生组织（WHO）统计，全球有超过10亿人患有神经系统疾病，其中神经和精神疾病占全球疾病负担的近10%。先进神经诊断技术的发展也推动了市场的发展，例如磁振造影、超音波扫描仪、电脑断层扫描仪和正子断层扫描(PET) 扫描仪，这些技术可提供高解析度影像并有助于准确评估神经结构和功能。然而，创新神经诊断设备和程序的高成本可能会限制市场成长。从积极的一面来看，新兴国家不断增长的医疗保健投资为市场参与者提供了有利可图的机会。加强遗传药理学和个人化医疗领域的研发也预示着预测期内市场的扩张。

研究的主要特点：

• 该报告对全球神经诊断市场进行了深入分析，并提供了预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%），以2023年为基准年。
• 它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
• 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
• 它根据以下参数描述了全球神经诊断市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
• 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球神经诊断市场迎合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利害关係人可以透过用于分析全球神经诊断市场的各种策略矩阵轻鬆做出决策。

目录

第一章：研究目标与假设

• 研究目标
• 假设
• 缩写

第 2 章：市场范围

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map (COM)

第 3 章：市场动态、法规与趋势分析

• 市场动态
  • 司机
  • 限制
  • 机会
• 影响分析
• 市场走向
• 最近的发展
• 收购和合作场景
• 产品发布/批准
• 资金和投资
• PEST分析
• 波特的分析

第 4 章：全球神经诊断市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第 5 章：全球神经诊断市场，依产品类型，2019 - 2031 年（十亿美元）

• 概述
• 脑电图 (EEG) 系统
• 磁振造影 (MRI) 系统
• 超音波成像系统
• 电脑断层扫描 (CT) 扫描仪
• 试剂及耗材
• 其他的

第 6 章：全球神经诊断市场，按治疗领域，2019 - 2031 年（十亿美元）

• 概述
• 神经退化性疾病
• 睡眠障碍
• 中风
• 癫痫
• 其他的

第 7 章：全球神经诊断市场，按最终用户划分，2019 - 2031 年（十亿美元）

• 概述
• 医院
• 诊断中心
• 门诊护理中心
• 其他的

第 8 章：全球神经诊断市场，按地区划分，2019 - 2031 年（十亿美元）

• 介绍
• 北美洲
• 我们
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 拉丁美洲其他地区
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 东协
• 澳洲
• 韩国
• 亚太地区其他地区
• 中东
• 海湾合作委员会
• 以色列
• 中东其他地区
• 非洲
• 北非
• 中非
• 南非

第 9 章：竞争格局

• 公司简介
  • Koninklijke Philips NV
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • Bio-Rad Laboratories Inc.
  • Advanced Brain Monitoring, Inc.
  • Nihon Kohden Corporation
  • Mitsar Co. LTD.
  • EMS Biomedical
  • Mennen Medical
  • Natus Medical Incorporated
  • Medicaid Systems
  • Fujirebio
  • FONAR Corp
  • ANT Neuro
  • NEUROLITE AG
  • Atlantic Health System

第 10 章：分析师观点

• 命运之轮
• 分析师观点
• 连贯的机会图

第 11 章：参考文献与研究方法

• 参考
• 研究方法论

The neurodiagnostics market is estimated to be valued at USD 8.66 Bn in 2024 and is expected to reach USD 14.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Figure. Neurodiagnostics Market Share (%), By Region 2024

Neurodiagnostics refers to the diagnosis of neurological disorders through various imaging and monitoring techniques. It involves the evaluation of the central and peripheral nervous system for any abnormalities. The neurodiagnostics market has been witnessing significant growth over the past few years due to the rising incidence of neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and various cancers affecting the nervous system. Advancements in neuroimaging technologies and development of novel biomarkers have enabled the early and accurate diagnosis of these conditions. Furthermore, the growing geriatric population who are more susceptible to neurological diseases, increasing healthcare expenditures, and availability of reimbursement are some of the key factors expected to drive the demand for neurodiagnostics in the coming years

Market Dynamics:

The global neurodiagnostics market is primarily driven by the rising prevalence of neurological disorders worldwide. According to the World Health Organization (WHO), over 1 billion people suffer from neurological disorders globally with neurological and mental disorders accounting for nearly 10% of the global disease burden. The market is also being propelled by the development of advanced neurodiagnostic technologies such as magnetic resonance imaging, ultrasound scanners, computed tomography scanners, and positron emission tomography (PET) scanners which provide high resolution images and aid accurate evaluation of neurological structures and functions. However, the market growth can be restrained by the high cost of innovative neurodiagnostic devices and procedures. On the positive side, growing healthcare investment in emerging nations presents lucrative opportunities for market players. Intensifying R&D in the fields of pharmacogenetics and personalized medicine also bodes well for the market expansion over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global neurodiagnostics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global neurodiagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global neurodiagnostics market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurodiagnostics market.

Detailed Segmentation-

• By Product Type:
  • Electroencephalogram (EEG) Systems
  • Magnetic Resonance Imaging (MRI) Systems
  • Ultrasound Imaging Systems
  • Computed Tomography (CT) Scanner
  • Reagents & Consumables
  • Others
• By Therapeutic Area:
  • Neurodegenerative Diseases
  • Sleep Disorders
  • Stroke
  • Epilepsy
  • Others
• By End User:
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Koninklijke Philips N.V
  • Siemens Healthcare GmbH
  • Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • Bio-Rad Laboratories Inc.
  • Advanced Brain Monitoring, Inc.
  • Nihon Kohden Corporation
  • Mitsar Co. LTD.
  • EMS Biomedical
  • Mennen Medical
  • Natus Medical Incorporated
  • Medicaid Systems
  • Fujirebio
  • FONAR Corp
  • ANT Neuro
  • NEUROLITE AG
  • Atlantic Health System

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Neurodiagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Neurodiagnostics Market, By Product Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Electroencephalogram (EEG) Systems
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Magnetic Resonance Imaging (MRI) Systems
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ultrasound Imaging Systems
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Computed Tomography (CT) Scanner
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Reagents & Consumables
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Neurodiagnostics Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Neurodegenerative Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Sleep Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Stroke
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Epilepsy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Neurodiagnostics Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Care Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Neurodiagnostics Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
  • Koninklijke Philips N.V
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • Bio-Rad Laboratories Inc.
  • Advanced Brain Monitoring, Inc.
  • Nihon Kohden Corporation
  • Mitsar Co. LTD.
  • EMS Biomedical
  • Mennen Medical
  • Natus Medical Incorporated
  • Medicaid Systems
  • Fujirebio
  • FONAR Corp
  • ANT Neuro
  • NEUROLITE AG
  • Atlantic Health System

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact